Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not professional

advice and should not be used in lieu of obtaining advice from a qualified health care provider.

And now on to the show. Welcome to Helix Talk Episode 70. I'm your co-host Dr. Kane. I'm

Dr. Schumann. And unfortunately Dr. Patel is unable to be with us,

but we were fortunate enough to have Dr. Abbey Lydden join us today. Thank you so much. Yes, it's a pleasure

to be here. And today's episode is entitled, Does Rosuvastatin really cause 42 adverse drug

reactions, identifying true ADRs to improve your patient counseling. Essentially, the purpose of today's episode is to talk a little bit about how ADRs are reported

in mostly tertiary drug references like up-to-date, micromedics, and things like that,

and how to help discriminate when you're trying to counsel a patient what is a true adverse drug reaction

versus what is kind of background noise such as headache or insomnia

or diarrhea, things like that.

So if you kind of imagine, you need to counsel a patient on a new prescription for, let's say,

Rousseauvastatin.

We're just picking a random drug.

And as we talked about in episode 69, if you're in Illinois, this is now a requirement

that all pharmacists are now counseling

all patients on all new prescriptions.

And it's been a little while, a couple years since you had Dr. Patel's dyslipidemia lecture,

and you pull up to date to try to figure out what am I going to talk about.

I remember my algaes, but what else do I need to talk about in terms of resubastatin?

...